GC WellBeing Corporation (KOSDAQ:234690)
South Korea · Delayed Price · Currency is KRW 11,230
+490 (4.56%)
At close: Oct 23, 2026
GC WellBeing Revenue
GC WellBeing had revenue of 52.08B KRW in the quarter ending June 30, 2026, with 33.81% growth. This brings the company's total for the last twelve months to 192.21B, up 35.53% year-over-year. In the year 2025, GC WellBeing had annual revenue of 164.68B with 23.08% growth. That makes GC WellBeing the 19,934th largest company in the world by revenue and 1,060th in South Korea.
Revenue (ttm)
192.21B
Revenue Growth
+35.53%
P/S Ratio
1.05
Revenue / Employee
573.76M
Employees
335
Market Cap
201.65B
Revenue by Segment
- Prescription Drugs 134.21B 80.4%
- Health Functional Food 32.80B 19.6%
Fiscal year ended Dec 31, 2025 See the full GC WellBeing breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 164.68B | 30.88B | 23.08% |
| Dec 31, 2024 | 133.80B | 13.27B | 11.01% |
| Dec 31, 2023 | 120.53B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.